Alerts will be sent to your verified email
Verify Email
YASHCHEM
|
Yash Chemex
|
Rishiroop
|
Novelix Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.5 % | 17.7 % | -17.5 % |
|
5yr average Equity Multiplier
|
2.4 | 1.13 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
1.2 | 0.64 | 0.84 |
|
5yr Avg Net Profit Margin
|
2.22 % | 25.98 % | -14.11 % |
|
Price to Book
|
2.46 | 0.7 | 5.59 |
|
P/E
|
54.9 | 24.45 | 171.93 |
|
5yr Avg Cash Conversion Cycle
|
190.93 Days | 44.14 Days | 29.1 Days |
|
Inventory Days
|
49.42 Days | 65.11 Days | 34.04 Days |
|
Days Receivable
|
159.09 Days | 53.94 Days | 55.38 Days |
|
Days Payable
|
79.4 Days | 58.0 Days | 55.7 Days |
|
5yr Average Interest Coverage Ratio
|
4.48 | 120.62 | -17.77 |
|
5yr Avg ROCE
|
10.78 % | 17.15 % | -15.4 % |
|
5yr Avg Operating Profit Margin
|
2.43 % | 11.16 % | -16.49 % |
|
5 yr average Debt to Equity
|
0.32 | 0.0 | 0.05 |
|
5yr CAGR Net Profit
|
1.53 % | -18.69 % | 35.78 % |
|
5yr Average Return on Assets
|
2.62 % | 15.78 % | -13.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
64.46 % | 73.49 % | 53.33 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
3.45 % | 0.18 % | -13.59 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Yash Chemex
|
Rishiroop
|
Novelix Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|